Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | KDM3B | Q7LBC6 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | DPYD | Q12882 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | HBB | P68871 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL119748 | 0.80 | GAA (0.48) | GAAKDM3BLMNADPYDALDH1A1 | |
| SCHEMBL127493 | 0.79 | KDM3B (0.64) | GAAKDM3BLMNADPYDALDH1A1 | |
| Water SCHEMBL4487821 | 0.78 | KDM3B (0.62) | GAAKDM3BLMNADPYDALDH1A1 | |
| Hydrochloric Acid SCHEMBL11439523 | 0.78 | KDM3B (0.62) | GAAKDM3BLMNADPYDALDH1A1 | |
| SCHEMBL8775721 | 0.76 | LMNA (0.48) | GAAKDM3BLMNADPYDALDH1A1 | |
| SCHEMBL65890 | 0.76 | GAA (0.48) | GAAKDM3BLMNADPYDALDH1A1 | |
| SCHEMBL1052427 | 0.76 | GAA (0.48) | GAAKDM3BLMNADPYDALDH1A1 | |
| SCHEMBL9220471 | 0.76 | GAA (0.48) | GAAKDM3BLMNADPYDALDH1A1 | |
| SCHEMBL933035 | 0.76 | DPYD (0.48) | GAAKDM3BLMNADPYDALDH1A1 | |
| SCHEMBL190958 | 0.74 | GAA (0.50) | GAAKDM3BLMNADPYDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230407419-A1 | Rapid Diagnostic Test for LAMP | NEW ENGLAND BIOLABS, INC. (US) | 2023-12-21 | — | — | US | disclosed |
| US-11732315-B2 | Rapid diagnostic test for lamp | NEW ENGLAND BIOLABS, INC. (US) | 2023-08-22 | — | — | US | disclosed |
| US-20230048863-A1 | Rapid Diagnostic Test for LAMP | NEW ENGLAND BIOLABS, INC. (US) | 2023-02-16 | — | — | US | disclosed |
| US-20230022745-A1 | Methods for Labeling a Population of RNA Molecules | NEW ENGLAND BIOLABS, INC. (US) | 2023-01-26 | — | — | US | disclosed |
| EP-4118233-A1 | A RAPID DIAGNOSTIC TEST FOR LAMP | New England Biolabs, Inc. (US) | 2023-01-18 | — | — | EP | disclosed |
| EP-4110945-A2 | A RAPID DIAGNOSTIC TEST FOR LAMP | New England Biolabs, Inc. (US) | 2023-01-04 | — | — | EP | disclosed |
| US-11525166-B2 | Rapid diagnostic test for LAMP | NEW ENGLAND BIOLABS, INC. (US) | 2022-12-13 | — | — | US | disclosed |
| US-11479766-B2 | Methods for labeling a population of RNA molecules | NEW ENGLAND BIOLABS, INC. (US) | 2022-10-25 | — | — | US | disclosed |
| US-20220213564-A1 | Rapid Diagnostic Test for LAMP | NEW ENGLAND BIOLABS, INC. (US) | 2022-07-07 | — | — | US | disclosed |
| US-20220195424-A1 | Chemical Capping for Template Switching | NEW ENGLAND BIOLABS, INC. (US) | 2022-06-23 | — | — | US | disclosed |
| US-11345970-B2 | Rapid diagnostic test for LAMP | NEW ENGLAND BIOLABS, INC. (US) | 2022-05-31 | — | — | US | disclosed |
| WO-2022040443-A2 | A RAPID DIAGNOSTIC TEST FOR LAMP | NEW ENGLAND BIOLABS, INC. (US) | 2022-02-24 | — | — | WO | disclosed |
| US-20210404024-A1 | Rapid Diagnostic Test for LAMP | NEW ENGLAND BIOLABS, INC. (US) | 2021-12-30 | — | — | US | disclosed |
| WO-2021183921-A1 | A RAPID DIAGNOSTIC TEST FOR LAMP | NEW ENGLAND BIOLABS, INC. (US) | 2021-09-16 | — | — | WO | disclosed |
| WO-2020231697-A1 | CHEMICAL CAPPING FOR TEMPLATE SWITCHING | NEW ENGLAND BIOLABS, INC. (US) | 2020-11-19 | — | — | WO | disclosed |
| US-20180195061-A1 | Methods for Labeling a Population of RNA Molecules | NEW ENGLAND BIOLABS, INC. (US) | 2018-07-12 | — | — | US | disclosed |
| EP-2272856-B1 | SEQUENCE-SPECIFIC NUCLEIC ACID PURIFICATION METHOD MANNER | JAPAN ADV INST SCIENCE & TECH (JP) | 2015-11-04 | — | — | EP | disclosed |
| US-9157885-B2 | Method of electrochemically detecting target substance, method of electrochemically detecting analyte, test chip, and detection set | SYSMEX CORPORATION (JP) | 2015-10-13 | — | — | US | disclosed |
| US-20120080324-A1 | METHOD OF ELECTROCHEMICALLY DETECTING TARGET SUBSTANCE, METHOD OF ELECTROCHEMICALLY DETECTING ANALYTE, TEST CHIP, AND DETECTION SET | SYSMEX CORPORATION (JP) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180195061-A1 | Methods for Labeling a Population of RNA Molecules | RNGTT, RNMT, MTAP | GAA 465/4885KDM3B 1477/4885LMNA 2087/4885 |
| US-11479766-B2 | Methods for labeling a population of RNA molecules | RNGTT, RNMT, MTAP | GAA 465/4885KDM3B 1477/4885LMNA 2087/4885 |
| US-20230022745-A1 | Methods for Labeling a Population of RNA Molecules | RNGTT, RNMT, MTAP | GAA 465/4885KDM3B 1477/4885LMNA 2087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.